default author photo

Chen Yao

Peking University - Clinical Research Institute

SCHOLARLY PAPERS

3

DOWNLOADS

385

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Efficacy and Safety of Qiliqiangxin in Patients with Heart Failure and Reduced Ejection Fraction: The QUEST Randomised Clinical Trial

Number of pages: 39 Posted: 29 Jun 2023
Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, Nanjing Medical University - First Affiliated Hospital, The University of Hong Kong - School of Chinese Medicine, The University of Hong Kong - School of Chinese Medicine, Shanghai Jiao Tong University (SJTU) - Ren Ji Hospital, Sichuan Provincial People’s Hospital, Xi'an Jiaotong University (XJTU) - First Affiliated Hospital, Xinjiang Medical University - First Affiliated Hospital, Shandong University - Shandong Provincial Hospital, Sun Yat-sen University (SYSU) - The First Affiliated Hospital, The University of Hong Kong - Queen Mary Hospital, Liaocheng People's Hospital, Jiangmen Central Hospital - Department of Cardiovascular Disease, Xiuyan Manchu Autonomous County Central Peoples Hospital, Nantong University - Affiliated Hospital, Weixian Hospital of Traditional Chinese Medicine, Xinjiang Production and Construction Corps - First Division Hospital, Beijing University of Chinese Medicine - Sunsimiao Hospital, Harbin Medical University - First Affiliated Hospital, Zouping People's Hospital, Workers' Hospital of Handan Iron and Steel Group Co., North Sichuan Medical College - Affiliated Hospital, Shanxi Medical University - The Second Affiliated Hospital, The Second People's Hospital of Bengbu, Pidu District People’s Hospital, Luoyang Central Hospital, Peking University - Clinical Research Institute, Peking University - Clinical Research Institute, Nanjing Medical University - First Affiliated Hospital, University of Michigan at Ann Arbor - Institute for Heart and Brain Health, Hebei Yiling Pharmaceutical Research Institute - National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine and Nanjing Medical University - First Affiliated Hospital
Downloads 187 (405,402)

Abstract:

Loading...

Qiliqiangxin (QLQX), Heart Failure, Traditional Chinese Medicine (TCM), Major Adverse Composite Endpoint, Cardiovascular Death, Hospitalisation for Heart Failure

2.

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Number of pages: 32 Posted: 25 May 2022
Nanjing Medical University - Nanjing First Hospital, Peking University - Center for Public Health and Epidemic Preparedness & Response, Guangdong Academy of Medical Sciences - Guangdong Provincial People's Hospital, Tianjin Medical University - General Hospital, Nanjing Medical University - Nanjing First Hospital, Zhengzhou First People’s Hospital, Xi'an Jiaotong University (XJTU) - The First Affiliated Hospital, Capital Medical University - Beijing Anzhen Hospital, General Hospital of Northern Theater Command, Nanjing Medical University - Nanjing First Hospital, Wuhan University - Zhongnan Hospital, Huazhong University of Science and Technology - Tongji Hospital, Chongqing Medical University - Second Affiliated Hospital, Tianjin Medical University - General Hospital, Guangdong Academy of Medical Sciences - Guangdong Provincial People's Hospital, Zhengzhou First People’s Hospital, Capital Medical University - Beijing Anzhen Hospital, General Hospital of Northern Theater Command, Wuhan Asia Heart Hospital, Wuhan Asia Heart Hospital, Xi'an Jiaotong University (XJTU) - The First Affiliated Hospital, Nanjing Medical University - Imaging Center, Huazhong University of Science and Technology - Tongji Hospital, Nanjing Medical University - Imaging Center, Peking University - Clinical Research Institute, Nanjing Medical University - State Key Laboratory of Reproductive Medicine, Peking University - Clinical Research Institute, Mount Sinai Health System - Zena and Michael A. Wiener Cardiovascular Institute and Nanjing Medical University - Department of Cardiology
Downloads 118 (604,538)

Abstract:

Loading...

Pulmonary Artery Denervation, Pulmonary arterial hypertension, 6-minute walk distance, pulmonary vascular resistance, clinical worsening

3.

A Core Outcome Set for Clinical Trials on Post COVID-19 Condition: 'What', 'When' and 'How' to Measure

Number of pages: 26 Posted: 14 Nov 2022
Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration, Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration, Capital Medical University - Beijing Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine - Second Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Henan University of Chinese Medicine - Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Government of the People's Republic of China - China-Japan Friendship Hospital, Naval Medical University (SMMU), Fujian University of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Anhui University of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences - Guanganmen Hospital, Shanghai University of Traditional Chinese Medicine - Shuguang Hospital, Shanghai University of Traditional Chinese Medicine - Shanghai Municipal Hospital of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine - First Affiliated Hospital, Peking University - Clinical Research Institute, Shanghai University of Traditional Chinese Medicine - Shuguang Hospital, China Academy of Chinese Medical Sciences, Chengdu University of Traditional Chinese Medicine - Affiliated Hospital, China Academy of Chinese Medical Sciences - Xiyuan Hospital, Sichuan University - Medical Device Regulatory Research and Evaluation Center, Sichuan University - West China Hospital, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Guangxi University of Chinese Medicine (GXTCM) - First Affiliated Hospital, Shanxi Medical University - Affiliated Hospital, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, affiliation not provided to SSRN, Wuhan Hospital of Traditional Chinese Medicine, First Hospital of Shijiazhuang, Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Tianjin University of Traditional Chinese Medicine - First Affiliated Hospital, Tianjin University of Traditional Chinese Medicine - Second Affiliated Hospital, Tianjin University of Traditional Chinese Medicine - Second Affiliated Hospital, Tianjin University of Traditional Chinese Medicine - Second Affiliated Hospital, Tianjin University of Traditional Chinese Medicine, Lanzhou University - Evidence-Based Medicine Center, Hunan University of Traditional Chinese Medicine - First Affiliated Hospital, Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration, Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration, Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration, Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration, China Academy of Chinese Medical Sciences, Sichuan University - Chinese Evidence-Based Medicine Centre, Tianjin University of Traditional Chinese Medicine and Tianjin University of Traditional Chinese Medicine - Key Laboratory of National Medical Products Administration
Downloads 80 (803,225)

Abstract:

Loading...

Core outcome set, Post COVID-19 condition, COVID-19, Clinical trials